Manufacture of pharmaceutical preparations
CAERUS CAPITAL AS
Revenue 2025
NOK 1.7m
Operating profit
NOK 1.6m
Equity
NOK 10.3m
Incorporated
2001
Share capital
NOK 50,000
Key figures · 2025
Current ratio
32.05
Equity ratio
97.0%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 96.2% | |
| Net margin (%%) | 131.6% | |
| Return on assets (%%) | 15.3% | |
| Likviditet | ||
| Current ratio | 32.05 | |
| Working capital | 9.4m | |
| Soliditet | ||
| Equity ratio (%%) | 97.0% | |
| Debt-to-equity ratio | 0.03 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.